11/5/24 19:14 | 11/2/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 9 | 49 | 29 | D | | | | | | | | | | | | | | |
11/5/24 19:14 | 11/4/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -25 | 8.19 | 0 | -3 | -10 | 29 | D | | | | | | | | | | | | | | |
5/3/24 18:29 | 5/1/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 3 | 33 | 14 | D | | | | | | | | | | | | | | |
5/3/24 18:29 | 5/2/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -16 | 10.32 | 0 | -2 | -10 | 14 | D | | | | | | | | | | | | | | |
1/23/24 19:17 | 1/20/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 267 | 297 | 356 | D | | | | | | | | | | | | | | |
1/23/24 19:17 | 1/22/24 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -49 | 0.3600 | 0 | -137 | -28 | 356 | D | | | | | | | | | | | | | | |
11/6/23 17:07 | 11/2/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 283 | | 227 | D | | | | | | | | | | | | | | |
11/6/23 17:07 | 11/3/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -50 | 0.4000 | 0 | -125 | -36 | 227 | D | | | | | | | | | | | | | | |
9/29/23 16:30 | 9/27/23 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | OH | D | | S | -22 | 3.91 | 0 | -6 | -5 | 109 | D | | | | | | | | | | | | | | |
9/22/23 16:05 | 9/20/23 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | OH | D | | S | -1 | 3.90 | 0 | 0 | 0 | 114 | D | | | | | | | | | | | | | | |
6/21/23 16:05 | 6/20/23 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | OH | D | | S | -2 | 4.45 | 0 | 0 | 0 | 115 | D | | | | | | | | | | | | | | |
3/23/23 16:00 | 3/21/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 103 | | 69 | D | | | | | | | | | | | | | | |
3/23/23 16:00 | 3/22/23 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -39 | 0.8200 | 0 | -47 | -41 | 69 | D | | | | | | | | | | | | | | |
3/21/23 17:13 | 3/20/23 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | NY | D | | S | -1 | 2.33 | 0 | 0 | 0 | 56 | D | | | | | | | | | | | | | | |
3/3/23 19:06 | 3/3/23 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | NY | D | | S | -2 | 2.38 | 0 | -1 | -2 | 57 | D | | | | | | | | | | | | | | |
10/18/22 16:13 | 10/15/22 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | M.d | 0 | 0.00 | 0 | 24 | | 13 | D | | | | | | | | | | | | | | |
10/18/22 16:13 | 10/17/22 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | S.d | -15 | 1.32 | 0 | -11 | -45 | 13 | D | | | | | | | | | | | | | | |
10/4/21 16:06 | 9/30/21 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | NY | DO | CEO | S | -49 | 1.09 | 0 | -45 | -7 | 605 | D | | | | | | | | | | | | | | |
4/2/21 19:12 | 3/31/21 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amoroso Michael | NY | DO | CEO | S | -85 | 1.87 | 0 | -45 | -7 | 650 | D | | | | | | | | | | | | | | |